Loading clinical trials...
Loading clinical trials...
The reirradiation of thoracic tumor is difficult. The possibility of surgery or re course radiotherapy is very small. In the NCCN guideline, only systemic treatment is recommended. However, the effect...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University Third Hospital
NCT02941458 · Thoracic Tumors
NCT07426094 · Prostate Cancer, Brachytherapy, and more
NCT06738160 · NSCLC, Stereotactic Body Radiation Therapy (SBRT), and more
NCT06987890 · Lung Cancer (NSCLC), Geriatric Assessment, and more
NCT06185062 · Pelvic Tumor, Thoracic Tumor
Peking University Third Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions